US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist

27.325
+0.565+2.11%

Trading Nov 27 11:41 ET

1.81BMarket Cap-10591P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-191.35%-55.34M

-7.84%-29.33M

-42.25%-40.64M

-3.43%-107.29M

-49.49%-32.53M

46.03%-18.99M

-22.26%-27.2M

-16.45%-28.57M

-70.31%-103.73M

-49.85%-21.76M

Net income from continuing operations

-10.09%-42.12M

-17.51%-35.84M

-11.74%-32.81M

-25.91%-141.43M

-63.50%-43.31M

-42.85%-38.26M

15.28%-30.5M

-27.38%-29.36M

-59.30%-112.33M

-31.46%-26.49M

Operating gains losses

--4K

--0

--8K

----

108.33%2K

200.00%1K

Depreciation and amortization

2.48%786K

5.42%797K

6.75%775K

3.87%3.01M

12.78%759K

14.31%767K

2.02%756K

-10.48%726K

-5.61%2.9M

-13.38%673K

Deferred tax

----

--0

----

--0

----

Other non cash items

----

-388.40%-6.86M

--0

Change In working capital

-248.34%-19.29M

286.99%2.82M

-314.25%-12.5M

445.36%13.46M

7,563.08%4.98M

195.79%13.01M

-109.85%-1.51M

46.90%-3.02M

-269.83%-3.9M

-96.30%65K

-Change in receivables

608.96%682K

-4.93%1.14M

95.55%-43K

-1,203.43%-2.28M

-1,403.80%-2.38M

-45.65%-134K

719.18%1.2M

-1,261.97%-967K

-111.12%-175K

-732.00%-158K

-Change in prepaid assets

-889.38%-14.35M

121.52%599K

-328.10%-6.21M

161.64%5.9M

352.01%4.14M

226.39%1.82M

-108.15%-2.78M

138.08%2.72M

-411.60%-9.57M

-521.54%-1.64M

-Change in payables and accrued expense

-20.88%6.71M

258.58%1.71M

-38.66%-4.78M

200.48%9.38M

61.34%3.88M

163.18%8.48M

-97.17%478K

-25.93%-3.45M

-14.51%3.12M

26.74%2.4M

-Change in other current assets

---9.64M

----

---3K

--0

----

--0

-Change in other current liabilities

-194.59%-2.69M

-60.00%-632K

-10.87%-1.47M

-83.05%462K

-23.69%-663K

555.93%2.85M

-2.07%-395K

-131.01%-1.33M

161.88%2.73M

2.55%-536K

Cash from discontinued investing activities

Operating cash flow

-191.35%-55.34M

-7.84%-29.33M

-42.25%-40.64M

-3.43%-107.29M

-49.49%-32.53M

46.03%-18.99M

-22.26%-27.2M

-16.45%-28.57M

-70.31%-103.73M

-49.85%-21.76M

Investing cash flow

Cash flow from continuing investing activities

310.08%47.76M

-4,114.00%-46.72M

-699.61%-315.21M

-217.61%-105.78M

-648.36%-171.16M

-49.51%11.65M

-95.40%1.16M

406.45%52.57M

141.61%89.94M

264.76%31.21M

Net PPE purchase and sale

-247.13%-545K

33.17%-274K

41.20%-344K

0.55%-1.82M

-183.40%-666K

54.49%-157K

39.08%-410K

-1.74%-585K

-46.36%-1.83M

33.62%-235K

Net investment purchase and sale

309.24%48.3M

-3,051.02%-46.45M

-692.37%-314.87M

-213.37%-103.96M

-642.15%-170.5M

-49.44%11.8M

-93.94%1.57M

385.20%53.15M

142.66%91.7M

269.15%31.45M

Net other investing changes

----

155.56%69K

--0

Cash from discontinued investing activities

Investing cash flow

310.08%47.76M

-4,114.00%-46.72M

-699.61%-315.21M

-217.61%-105.78M

-648.36%-171.16M

-49.51%11.65M

-95.40%1.16M

406.45%52.57M

141.61%89.94M

264.76%31.21M

Financing cash flow

Cash flow from continuing financing activities

382.10%1.24M

2,690.98%3.71M

62,740.35%436.11M

5,259.62%218.46M

15,482.37%217.37M

-88.86%257K

87.32%133K

128.29%694K

-98.50%4.08M

227.46%1.4M

Net common stock issuance

--0

--432.3M

--216.22M

--0

----

Proceeds from stock option exercised by employees

382.10%1.24M

2,690.98%3.71M

449.57%3.81M

-45.14%2.24M

-17.42%1.15M

-88.86%257K

87.32%133K

128.29%694K

64.42%4.08M

227.46%1.4M

Cash from discontinued financing activities

Financing cash flow

382.10%1.24M

2,690.98%3.71M

62,740.35%436.11M

5,259.62%218.46M

15,482.37%217.37M

-88.86%257K

87.32%133K

128.29%694K

-98.50%4.08M

227.46%1.4M

Net cash flow

Beginning cash position

51.43%42.74M

112.62%115.08M

18.30%34.81M

-24.82%29.43M

13.73%21.13M

-0.62%28.22M

113.98%54.12M

-24.82%29.43M

-10.71%39.14M

-74.26%18.58M

Current changes in cash

10.58%-6.34M

-179.31%-72.34M

225.03%80.26M

155.44%5.39M

26.13%13.68M

27.79%-7.09M

-933.30%-25.9M

278.30%24.69M

-106.99%-9.71M

132.83%10.85M

End cash Position

72.23%36.4M

51.43%42.74M

112.62%115.08M

18.30%34.81M

13.73%21.13M

-0.62%28.22M

113.98%54.12M

-24.82%29.43M

Free cash flow

-191.81%-55.88M

-7.23%-29.6M

-40.57%-40.98M

-3.36%-109.11M

-50.93%-33.2M

46.11%-19.15M

-20.46%-27.61M

-16.11%-29.15M

-69.83%-105.56M

-47.86%-22M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-191.35%-55.34M	-7.84%-29.33M	-42.25%-40.64M	-3.43%-107.29M	-49.49%-32.53M	46.03%-18.99M	-22.26%-27.2M	-16.45%-28.57M	-70.31%-103.73M	-49.85%-21.76M
Net income from continuing operations	-10.09%-42.12M	-17.51%-35.84M	-11.74%-32.81M	-25.91%-141.43M	-63.50%-43.31M	-42.85%-38.26M	15.28%-30.5M	-27.38%-29.36M	-59.30%-112.33M	-31.46%-26.49M
Operating gains losses	--4K	--0	--8K	----	----	----	----	----	108.33%2K	200.00%1K
Depreciation and amortization	2.48%786K	5.42%797K	6.75%775K	3.87%3.01M	12.78%759K	14.31%767K	2.02%756K	-10.48%726K	-5.61%2.9M	-13.38%673K
Deferred tax	----	----	----	--0	----	----	----	----	--0	----
Other non cash items	----	----	----	----	----	----	----	----	-388.40%-6.86M	--0
Change In working capital	-248.34%-19.29M	286.99%2.82M	-314.25%-12.5M	445.36%13.46M	7,563.08%4.98M	195.79%13.01M	-109.85%-1.51M	46.90%-3.02M	-269.83%-3.9M	-96.30%65K
-Change in receivables	608.96%682K	-4.93%1.14M	95.55%-43K	-1,203.43%-2.28M	-1,403.80%-2.38M	-45.65%-134K	719.18%1.2M	-1,261.97%-967K	-111.12%-175K	-732.00%-158K
-Change in prepaid assets	-889.38%-14.35M	121.52%599K	-328.10%-6.21M	161.64%5.9M	352.01%4.14M	226.39%1.82M	-108.15%-2.78M	138.08%2.72M	-411.60%-9.57M	-521.54%-1.64M
-Change in payables and accrued expense	-20.88%6.71M	258.58%1.71M	-38.66%-4.78M	200.48%9.38M	61.34%3.88M	163.18%8.48M	-97.17%478K	-25.93%-3.45M	-14.51%3.12M	26.74%2.4M
-Change in other current assets	---9.64M	----	----	---3K	--0	--0	----	----	--0	--0
-Change in other current liabilities	-194.59%-2.69M	-60.00%-632K	-10.87%-1.47M	-83.05%462K	-23.69%-663K	555.93%2.85M	-2.07%-395K	-131.01%-1.33M	161.88%2.73M	2.55%-536K
Cash from discontinued investing activities
Operating cash flow	-191.35%-55.34M	-7.84%-29.33M	-42.25%-40.64M	-3.43%-107.29M	-49.49%-32.53M	46.03%-18.99M	-22.26%-27.2M	-16.45%-28.57M	-70.31%-103.73M	-49.85%-21.76M
Investing cash flow
Cash flow from continuing investing activities	310.08%47.76M	-4,114.00%-46.72M	-699.61%-315.21M	-217.61%-105.78M	-648.36%-171.16M	-49.51%11.65M	-95.40%1.16M	406.45%52.57M	141.61%89.94M	264.76%31.21M
Net PPE purchase and sale	-247.13%-545K	33.17%-274K	41.20%-344K	0.55%-1.82M	-183.40%-666K	54.49%-157K	39.08%-410K	-1.74%-585K	-46.36%-1.83M	33.62%-235K
Net investment purchase and sale	309.24%48.3M	-3,051.02%-46.45M	-692.37%-314.87M	-213.37%-103.96M	-642.15%-170.5M	-49.44%11.8M	-93.94%1.57M	385.20%53.15M	142.66%91.7M	269.15%31.45M
Net other investing changes	----	----	----	----	----	----	----	----	155.56%69K	--0
Cash from discontinued investing activities
Investing cash flow	310.08%47.76M	-4,114.00%-46.72M	-699.61%-315.21M	-217.61%-105.78M	-648.36%-171.16M	-49.51%11.65M	-95.40%1.16M	406.45%52.57M	141.61%89.94M	264.76%31.21M
Financing cash flow
Cash flow from continuing financing activities	382.10%1.24M	2,690.98%3.71M	62,740.35%436.11M	5,259.62%218.46M	15,482.37%217.37M	-88.86%257K	87.32%133K	128.29%694K	-98.50%4.08M	227.46%1.4M
Net common stock issuance	--0	--0	--432.3M	--216.22M	--216.22M	--0	--0	--0	--0	----
Proceeds from stock option exercised by employees	382.10%1.24M	2,690.98%3.71M	449.57%3.81M	-45.14%2.24M	-17.42%1.15M	-88.86%257K	87.32%133K	128.29%694K	64.42%4.08M	227.46%1.4M
Cash from discontinued financing activities
Financing cash flow	382.10%1.24M	2,690.98%3.71M	62,740.35%436.11M	5,259.62%218.46M	15,482.37%217.37M	-88.86%257K	87.32%133K	128.29%694K	-98.50%4.08M	227.46%1.4M
Net cash flow
Beginning cash position	51.43%42.74M	112.62%115.08M	18.30%34.81M	-24.82%29.43M	13.73%21.13M	-0.62%28.22M	113.98%54.12M	-24.82%29.43M	-10.71%39.14M	-74.26%18.58M
Current changes in cash	10.58%-6.34M	-179.31%-72.34M	225.03%80.26M	155.44%5.39M	26.13%13.68M	27.79%-7.09M	-933.30%-25.9M	278.30%24.69M	-106.99%-9.71M	132.83%10.85M
End cash Position	72.23%36.4M	51.43%42.74M	112.62%115.08M	18.30%34.81M	18.30%34.81M	13.73%21.13M	-0.62%28.22M	113.98%54.12M	-24.82%29.43M	-24.82%29.43M
Free cash flow	-191.81%-55.88M	-7.23%-29.6M	-40.57%-40.98M	-3.36%-109.11M	-50.93%-33.2M	46.11%-19.15M	-20.46%-27.61M	-16.11%-29.15M	-69.83%-105.56M	-47.86%-22M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data